Data driven computational approaches to predicting protein-ligand binding are currently achieving unprecedented levels of accuracy on held-out test data sets.
Introduction
Molecular recognition is a fundamental requirement of biological systems.
The interactions between proteins and small molecules are central to biology, allowing cells to sense their surroundings and respond appropriately. Estimates place the number of small molecules that can be synthesized at ≈ 10 60 , yet 5 just a small fraction of potential protein-ligand interactions have been explored.
Finding novel interactions is of great importance to drug discovery and basic biology. Given the enormity of the search space, computational approaches can narrow down the possibilities. However, despite three decades of computational effort, biochemical experiments are still essential to determine the efficacy of ligand binding to a protein target [1, 2] . The results of computational analysis have been decidedly mixed: it is challenging to use even experimentally well-characterized ligand protein interactions to computationally design novel interactions [1, 2] , much less explore the vast space of possibilities.
There are three increasingly demanding tasks in protein-ligand binding pre-15 diction: virtual screening predicts whether a ligand binds to a given target;
affinity prediction predicts the binding affinity; and pose prediction identifies the molecular interactions causing binding to occur. In this review we focus on the first; the others have been reviewed elsewhere [3, 4] . Approaches to virtual screening can be categorised as physical or statistical. The idea of using first 20 principles physical models to describe protein-ligand interactions is attractive, however timescale and computational resource constraints mean that simplified descriptions of features such as protein flexibility, and solvent are necessary.
Even the most sophisticated docking algorithms cannot accurately reproduce large numbers of known interactions, much less predict new ones. Scoring func-25 tions can be empirical [5, 6, 7, 8, 9] or knowledge-based [10, 11, 12, 13, 14].
Significant expertise is required to encode physico-chemical interactions through the use of hand-tuned features and parameters, and can be highly specific to the system that they are designed for [15] .
Recently, the use of high throughput methods to screen large libraries of 30 proteins and small molecules and quantify their interactions has made it possible to correlate activity with representations of proteins and small molecules, to infer predictive models. Techniques from machine learning and artificial intel- with, often based on clear similarities to known success stories [33, 34] .
Definitively showing that these approaches generalise is perhaps the outstanding challenge facing this field today. In the search for novel pharmaceu- ticals, the ability to predict the binding of ligands that are chemically distinct from those in the training data is highly valuable, but much more challenging for 70 algorithms that are expert at identifying patterns among training set ligands.
The goal of this article is to review statistical approaches to molecular recognition in the context of protein-ligand binding, focusing on recent results that exploit DNNs (see figure 1 ). Here we briefly outline the basic steps of machine learning algorithm that predicts protein-ligand binding.
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Molecular Representation
There are almost as many choices for representation of the input data as there are for the machine learning algorithm employed [35, 36] . The simplest involve counting the numbers of different heavy atoms present in a ligand, together with other features such as hydrogen bond donors/acceptors, chiral centers and ring 80 systems [19][30**]. Some information about the chemical structure is retained by descriptors such as atom pairs or donor-acceptor pairs [37, 38] where each element has the form (atom type i) -(distance in bonds) -(atom type j).
More information is encoded by chemical fingerprints, for example MACCS keys [39] and ECFP fingerprints [40] ; fixed length binary descriptors which can 85 be generated by the package RDKit [41]. Here, each non-hydrogen atom is used as a centre from which fragments are generated by extending radially from the centre along bonds to neighbouring atoms; the maximum radius considered N is encoded in the name as ECFP2N . A unique identifier is assigned to each fragment, and the set of identifiers for a molecules is mapped to a fixed length 90 bit vector to yield the molecular fingerprint.
This abundance raises the question of which representation is most useful for different prediction tasks. Recently the suggestion has been made that it may be more effective to also learn the molecular representation itself, alongside the metric and corresponding embedding space used to distinguish active from 
Representation and Sampling Noise
One rational for the finding that more complex representations can result 100 in little improvement is noise due to finite sampling. The basic premise of any predictive algorithm is that similarities among known interaction partners can reveal the requirements of the binding site, and thus predict novel interactions.
A straightforward approach is to compile the set of ligands known to bind to a 5 protein receptor of interest, and identify those features that show statistically 105 significant enrichment among this set [44] . However, because there are only finitely many samples (i.e. known ligand binders), some features will be enriched purely by chance. This chance similarity increases with the number of variables, so representations that have more variables will lead to greater random similarity between features. For DNNs in particular, representations with thousands or 110 even millions of features have recently been employed [24][21*, 22*]; although these algorithms have the ability to share information between targets it is still important that the level of chance similarity between small molecules is quantified and accounted for.
This phenomena has been carefully studied in the field of random matrix 115 theory, which provides a null distribution that describes the similarity between samples (ligands) that can be expected by chance due to finite sampling as a function of the number of samples available, and the number of variables present in the ligand descriptor [45] [46*]. A simpler method for generating this null distribution simply involves computing the covariance matrices of multiple 120 sets of n random ligands, where n is the sample size, using the same ligand descriptor for each set, and so obtaining the distribution of the largest entries that occur due to finite sampling noise. A similar approach can be taken for any measure of molecular similarity, defining a statistical null distribution with which to compare putative active molecules.
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Benchmark Datasets
The application of machine learning algorithms to problems such as proteinligand binding is facilitated by the availability of large experimental datasets.
For both algorithms that require 3D complexes and those that work with 2D ligand structures, a number of benchmark datasets have emerged that allow 
Choice of Algorithm
Early linear regression methods were soon super-seeded by nonlinear models constructed using early versions of neural networks, among other techniques.
Algorithms such as support vector machines [51, 52], Gaussian Procceses [53, 54] 145 and Random Forests (RF) [55, 15, 56, 43] have all received significant attention within the community. One advantage of these approaches is that many allow some level of interpretability, enabling the medicinal chemist to rationalise and evaluate the resulting model. This is more challenging for DNNs (see figure 1 ), which have recently been found to be highly successful on a variety of different 150 tasks including computer vision [57] and speech recognition [58] . In the last few years there has been a burst of activity involving the construction of DNNs to and Gaussian process regression [53] were used by the winning entry, Dahl suggests that the DNN was the main cause of the performance increase.
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A careful comparison of DNNs and RFs at protein-binding prediction over 15 datasets found that the best R 2 values over all parameter sets are obtained 7 using DNNs for five datasets, and using RFs for one, with mixed results for the remaining datasets. For refined parameter ranges, this increased to nine datasets for DNNs compared to one for RFs , leading the authors to conclude 165 that DNNs have the potential to outperform RFs generally [20**].
A crucial issue with DNNs is the set of algorithmic parameters affecting predictive performance that must be decided by the researcher, such as network size, choice of activation functions and use of dropout [65] , which are distinct from parameters that are learned from the data. In general it is not computa- However, it would likely be unable to make accurate predictions for additional molecules that it had not previously seen before.
For chemical data, a key problem is to define what constitutes a distinct
partitioning between test and training data. Simply requiring that the molecules are different from one another is not enough [31, 19, 32] [30**]. Machine learning 190 algorithms are extremely effective at learning any feature that distinguishes samples from different classes (such as binding and non-binding). This means that it is necessary to go further, and require that active molecules do not share any nuisance similarity or property that distinguishes them from inactive molecules, while not being the crucial molecular feature that enables binding.
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The situation is complicated by the fact that in most cases the crucial feature that enables binding is not known -indeed identifying these feature(s) is the ultimate goal of the exercise. However relatively simple devices such as synthetic datasets, in which binding is said to occur if particular logical combinations of features are present, or bias measures that quantify simple molecular similarities 200 can be surprisingly effective.
Despite these challenges, this is an exciting time for building models of protein-ligand interactions. One could hope that a review written five years hence would be filled more with victories than warnings. [30] I. Wallach, A. Heifets, Most ligand-based benchmarks measure overfitting rather than accuracy, arXiv preprint arXiv:1706.06619 (2017). ** Using a novel metric the authors demonstrate that many benchmark datasets 315 are biased. This implies that machine learning algorithms trained on these datasets may not generalize beyond the domain of the training data as well as might be expected, given the reported performance on held out test data. 
